Advertisement
Screener

OptimizeRx Corporation (OPRX) Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities

2.8 / 5 stars · 68/120 Roast Me

OptimizeRx Corporation Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities

OptimizeRx Corporation (OPRX) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of -$6.19 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-13

  • OptimizeRx Corporation increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was $1.80M, a 45.22% decline year-over-year.
  • OptimizeRx Corporation increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was -$7.99M, a 1035.48% decline year-over-year.
  • OptimizeRx Corporation increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was $1.46M, a 52.10% decline year-over-year.
  • OptimizeRx Corporation increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was -$2.23M, a 933.33% decline year-over-year.
  • OptimizeRx Corporation increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was $3.37M, a 220.42% increase from fiscal 2024.
  • OptimizeRx Corporation increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was $1.05M, a 19.19% decline from fiscal 2023.
  • OptimizeRx Corporation increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was $1.30M.
Period endIncrease (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 monthIncrease (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 monthIncrease (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 monthIncrease (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month
2026-06-30$1.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
-$6.19M
10-Q · filed 2026-08-13
-$4.73M
derived: sum of 3 quarters · filed 2026-08-13
-$6.95M
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31-$7.99M
10-Q · filed 2026-05-13
-$6.53M
derived: sum of 2 quarters · filed 2026-05-13
-$8.75M
derived: sum of 3 quarters · filed 2026-05-13
-$5.47M
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31$1.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
-$764.00K
derived: sum of 2 quarters · filed 2026-03-12
$2.52M
derived: sum of 3 quarters · filed 2026-08-13
$3.37M
10-K · filed 2026-03-12
2025-09-30-$2.23M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$1.06M
derived: sum of 2 quarters · filed 2026-08-13
$1.91M
10-Q · filed 2025-11-07
$4.96M
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30$3.28M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
$4.14M
10-Q · filed 2026-08-13
$7.19M
derived: sum of 3 quarters · filed 2026-08-13
$7.46M
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31$854.00K
10-Q · filed 2026-05-13
$3.90M
derived: sum of 2 quarters · filed 2026-05-13
$4.17M
derived: sum of 3 quarters · filed 2026-05-13
$2.27M
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31$3.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
$3.32M
derived: sum of 2 quarters · filed 2026-03-12
$1.42M
derived: sum of 3 quarters · filed 2026-03-12
$1.05M
10-K · filed 2026-03-12
2024-09-30$267.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
-$1.64M
derived: sum of 2 quarters · filed 2025-11-07
-$2.00M
10-Q · filed 2025-11-07
-$1.20M
derived: sum of 4 quarters · filed 2025-11-07
2024-06-30-$1.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08
-$2.26M
10-Q · filed 2025-08-08
-$1.47M
derived: sum of 3 quarters · filed 2025-08-08
2024-03-31-$362.00K
10-Q · filed 2025-05-13
$432.00K
derived: sum of 2 quarters · filed 2025-05-13
2023-12-31$794.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20
$1.30M
10-K · filed 2025-03-20
2023-09-30$509.00K
10-Q · filed 2024-11-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
TEN Holdings, Inc. (XHLD)United States$0.152B
Future FinTech Group Inc. (FTFT)$0.144B
Datavault AI Inc. (DVLT)United States$0.144B-1.77
RESOURCES CONNECTION, INC. (RGP)United States$0.129B-3.84
DHI GROUP, INC. (DHX)United States$0.205B132.15
COMSCORE, INC. (SCOR)United States$0.073B-6.35
Research Solutions, Inc. (RSSS)United States$0.071B27.67
Getty Images Holdings, Inc. (GETY)United States$0.068B-2.33
FiscalNote Holdings, Inc. (NOTE)United States$0.065B
Bridger Aerospace Group Holdings, Inc. (BAER)United States$0.049B-9.14